Marshall L Stoller Selected Research

Nephrolithiasis

3/2022	Perspectives in primary hyperoxaluria - historical, current and future clinical interventions.
8/2021	Structure and elemental composition of Ceftriaxone induced pediatric nephrolithiasis.
1/2020	Fatty acid-binding protein 4 downregulation drives calcification in the development of kidney stone disease.
1/2018	Beginnings of nephrolithiasis: insights into the past, present and future of Randall's plaque formation research.
1/2018	A continuum of mineralization from human renal pyramid to stones on stems.
1/2017	Dietary Zinc and Incident Calcium Kidney Stones in Adolescence.
6/2016	Significant differences in struvite and cystine stone frequency seen among Chinese nephrolithiasis patients living in North America compared to those living in China.
4/2016	Coronary Artery Calcium Score and Association with Recurrent Nephrolithiasis: The Multi-Ethnic Study of Atherosclerosis.
2/2015	Dyslipidemia is associated with an increased risk of nephrolithiasis.
12/2014	Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women's Health Initiative report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marshall L Stoller Research Topics

Disease

31	Nephrolithiasis 03/2022 - 01/2002
23	Urinary Calculi (Urinary Calculus) 01/2018 - 04/2002
16	Kidney Calculi (Kidney Stone) 01/2020 - 06/2010
7	Calculi (Calculus) 06/2016 - 10/2002
6	Urolithiasis 10/2021 - 12/2002
6	Pathologic Constriction (Stenosis) 01/2018 - 01/2004
6	Neoplasms (Cancer) 09/2015 - 01/2003
4	Cystinuria 07/2017 - 09/2003
4	Diabetes Mellitus 12/2014 - 04/2010
4	Primary Hyperparathyroidism 02/2012 - 12/2007
3	Chronic Kidney Failure (Chronic Renal Failure) 03/2022 - 09/2003
3	Primary Hyperoxaluria (Oxaluria, Primary) 03/2022 - 01/2021
3	Hemorrhage 01/2018 - 03/2002
3	Hypertension (High Blood Pressure) 05/2013 - 02/2010
3	Hyperparathyroidism 03/2012 - 12/2007
3	Shock 07/2009 - 01/2002
3	Renal Insufficiency (Renal Failure) 06/2009 - 09/2003
3	Wounds and Injuries (Trauma) 12/2005 - 03/2002
3	Infections 12/2005 - 01/2003
2	Nephrocalcinosis 03/2022 - 01/2018
2	Gout 01/2019 - 10/2002
2	Xanthogranulomatous Pyelonephritis 01/2018 - 08/2002
2	Inborn Genetic Diseases (Disease, Hereditary) 07/2017 - 09/2003
2	Thrombosis (Thrombus) 09/2015 - 12/2004
2	False Aneurysm (Pseudoaneurysm) 09/2015 - 01/2008
2	Obesity 05/2013 - 12/2004
2	Hypercalciuria 02/2012 - 02/2009
2	Calcium Oxalate Nephrolithiasis 11/2009 - 03/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2006 - 09/2003
2	Fistula 08/2002 - 03/2002
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Hydronephrosis 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Urinary Retention 06/2018
1	Inverted Papilloma 06/2018
1	Fused Kidney 01/2018
1	Staghorn Calculi 01/2018
1	Adenoma (Adenomas) 01/2018
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2018
1	Pyonephrosis 01/2018
1	Atherosclerosis 04/2016
1	Aneurysm (Aneurysms) 09/2015
1	Chronic Pain 09/2015
1	Renovascular Hypertension (Goldblatt Syndrome) 09/2015
1	Flank Pain 09/2015

Drug/Important Bio-Agent (IBA)

21	CalciumIBA 01/2018 - 07/2002
9	Uric Acid (Urate)IBA 01/2019 - 10/2002
8	Calcium OxalateIBA 10/2021 - 03/2009
7	Cystine (L-Cystine)IBA 07/2017 - 12/2002
6	OxalatesIBA 03/2022 - 06/2010
6	SodiumIBA 01/2017 - 03/2009
6	Citric Acid (Citrate)FDA LinkGeneric 06/2010 - 07/2002
5	MineralsIBA 01/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2010
5	calcium phosphateIBA 12/2018 - 02/2012
5	CreatinineIBA 02/2012 - 02/2004
4	StruviteIBA 06/2016 - 04/2002
4	Dietary SodiumIBA 05/2012 - 03/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2014 - 01/2003
3	Dietary CalciumIBA 09/2014 - 04/2012
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
2	LipidsIBA 01/2018 - 02/2015
2	ZincIBA 01/2017 - 01/2015
2	Parathyroid Hormone (Parathormone)IBA 02/2012 - 02/2009
2	PotassiumIBA 06/2010 - 04/2010
2	Phosphates (Orthophosphate)IBA 06/2010 - 04/2010
2	ThiazidesIBA 04/2010 - 02/2009
1	nedosiranIBA 10/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2021
1	Phosphorus (Red Phosphorus)IBA 01/2021
1	PH.3IBA 01/2021
1	Fatty Acid-Binding ProteinsIBA 01/2020
1	Amino Acids FDA Link 07/2017
1	Cysteine (L-Cysteine)FDA Link 07/2017
1	Thioctic Acid (Lipoic Acid)IBA 03/2017
1	Phytic Acid (Inositol Hexaphosphate)IBA 01/2017
1	Durapatite (Hydroxylapatite)IBA 07/2015
1	Diphosphonates (Bisphosphonates)IBA 07/2015
1	HDL LipoproteinsIBA 02/2015
1	MetalsIBA 01/2015
1	Xanthine DehydrogenaseIBA 01/2015
1	Hormones (Hormone)IBA 12/2014

Therapy/Procedure

12	Nephrectomy 01/2018 - 08/2002
6	Therapeutics 03/2022 - 01/2003
6	Percutaneous Nephrolithotomy 01/2017 - 01/2002
5	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 07/2009 - 01/2002
4	Autologous Transplantation 09/2015 - 04/2003
4	Operative Time 01/2010 - 02/2004
3	Nephrotomy 01/2018 - 03/2007
3	Stents 01/2018 - 01/2004
3	Morcellation 01/2018 - 01/2003
3	Synchrotrons 01/2015 - 02/2013
2	Solid-State Lasers 06/2018 - 01/2018
2	Microbubbles 01/2018 - 07/2015
2	Parathyroidectomy 03/2012 - 02/2012
2	Kidney Transplantation 08/2004 - 01/2002
2	Conservative Treatment 04/2004 - 01/2002
1	Punctures 01/2020
1	General Anesthesia 01/2018
1	Endoscopes 01/2017